Zhijun Geng

Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study

Tianqi Zhang, Zhijun Geng, Mengxuan Zuo et al. · Signal Transduction and Targeted Therapy · 2023 · 122 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Atractylenolide III ameliorates spinal cord injury in rats by modulating microglial/macrophage polarization

Mengtong Xue, Wen‐Jie Sheng, Xue Song et al. · CNS Neuroscience & Therapeutics · 2022 · 81 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy

Yan Meng, Xiao Zhang, Bin Zhang et al. · European Radiology · 2023 · 51 citations · Full text

Medicine, Radiology, Surgery +17

Radiomics Analysis of Susceptibility Weighted Imaging for Hepatocellular Carcinoma: Exploring the Correlation between Histopathology and Radiomics Features

Zhijun Geng, Yunfei Zhang, Shutong Wang et al. · Magnetic Resonance in Medical Sciences · 2020 · 35 citations · Full text

Medicine, Oncology, Radiology +17

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival

Lidi Ma, Kan Deng, Cheng Zhang et al. · Frontiers in Oncology · 2022 · 29 citations · Full text

Medicine, Oncology, Surgery +17